Literature DB >> 3338501

Hepatitis B markers in Lancashire police officers.

P Morgan-Capner1, P Hudson, A Armstrong.   

Abstract

A total of 284 Lancashire police officers each with a minimum of 5 years experience was tested for evidence of hepatitis B infection. None was hepatitis B surface antigen positive (HBsAg). Three were positive for both antibody to hepatitis B core antigen (anti-HBc) and HBsAg (anti-HBs). Five were positive for anti-HBc alone. Thus the overall prevalence was 2.8% which is within the range reported for blood donors in the UK. There was no association with working in the drug squad or custody office but there was a higher prevalence in those who had worked in the scene-of-crime's squad. However, the numbers were small, and of this group of 28 officers, 2 of the 3 with detectable hepatitis B markers were positive for anti-HBc alone. Therefore for police officers in mixed rural/urban areas of the UK, routine administration of hepatitis B vaccine is not justified although special consideration should be given to those working in selected groups. Further studies are required to ascertain whether there may be an increased risk for police officers working in conurbations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3338501      PMCID: PMC2249199          DOI: 10.1017/s0950268800065638

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  19 in total

1.  Prevalence of hepatitis B markers among district general hospital staff.

Authors:  A M Abbas; M D Denton; R A Francis
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-20

2.  Hepatitis B vaccination policy.

Authors: 
Journal:  Lancet       Date:  1983-03-05       Impact factor: 79.321

3.  Non-A, non-B hepatitis surrogate testing of blood donations.

Authors: 
Journal:  Lancet       Date:  1987-06-13       Impact factor: 79.321

4.  Who should be immunised against hepatitis B?

Authors:  A J Zuckerman
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10

5.  New hepatitis B vaccines.

Authors:  E M Vandervelde; P P Mortimer
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-09

6.  Immunization against hepatitis B: report on a WHO meeting on viral hepatitis in Europe.

Authors:  F Deinhardt; A J Zuckerman
Journal:  J Med Virol       Date:  1985-11       Impact factor: 2.327

7.  The value of screening blood donors for antibody to hepatitis B core antigen.

Authors:  A C Archer; B J Cohen; P P Mortimer
Journal:  J Clin Pathol       Date:  1983-08       Impact factor: 3.411

8.  The prevalence of hepatitis B serological markers in dental personnel.

Authors:  C G Cumming; J F Peutherer; G L Smith
Journal:  J Infect       Date:  1986-03       Impact factor: 6.072

9.  Viral hepatitis markers in blood donors and patients with a history of jaundice.

Authors:  E A Follett; A Barr; R J Crawford; R Mitchell
Journal:  Lancet       Date:  1980-02-02       Impact factor: 79.321

10.  Prevalence of hepatitis B markers in patients and staff in a hospital for the mentally handicapped.

Authors:  P A Holt; B Goodall; E M Lees; M H Hambling
Journal:  J Hosp Infect       Date:  1986-01       Impact factor: 3.926

View more
  2 in total

1.  The risk of acquiring Q fever on farms: a seroepidemiological study.

Authors:  D R Thomas; L Treweek; R L Salmon; S M Kench; T J Coleman; D Meadows; P Morgan-Capner; E O Caul
Journal:  Occup Environ Med       Date:  1995-10       Impact factor: 4.402

2.  Hepatitis B markers in West Yorkshire firemen.

Authors:  B A Crosse; C Teale; E M Lees
Journal:  Epidemiol Infect       Date:  1989-10       Impact factor: 2.451

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.